Migraine
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male or female participants aged >= 18 years-old 2. Primary diagnosis of migraine according to ICHD-3 3. Migraine attacks present for more than 1 year 4. Rimegepant is prescribed for the acute treatment of migraine by physician 5. Written informed consent must be obtained before participant is enrolled
Exclusion criteria
Exclusion criteria: 1. Severe impairment of speech, vision, memory or cognition, or other factors that affectcommunication and ability to complete questionnaires and follow-up 2. Lack of necessary digital tools to complete questionnaires on a digital platform 3. History of hypersensitivity reaction to Rimegepant or to any of its components 4. Participants with severe hepatic impairment or end-stage renal disease 5. Any situation that the investigator believes may affect the patient's participation in thestudy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS;The headache begins to ease;Drug Satisfaction Questionnaire; | — |
Countries
Chinese
Contacts
The First Medical Center of the General Hospital of the People's Liberation Army